VolitionRX - Stock Price History | VNRX

Historical daily share price chart and data for VolitionRX since 2021 adjusted for splits. The latest closing stock price for VolitionRX as of September 24, 2021 is 3.25.
  • The all-time high VolitionRX stock closing price was 6.50 on February 08, 2021.
  • The VolitionRX 52-week high stock price is 6.67, which is 105.2% above the current share price.
  • The VolitionRX 52-week low stock price is 2.85, which is 12.3% below the current share price.
  • The average VolitionRX stock price for the last 52 weeks is 3.57.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
VolitionRX Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 3.6512 4.6700 5.1600 2.4700 3.8900 -17.93%
2019 3.8131 2.2000 6.4200 2.1900 4.7400 161.88%
2018 2.3943 2.8100 3.9500 1.5700 1.8100 -38.44%
2017 3.4693 4.7900 5.2600 2.1000 2.9400 -35.67%
2016 3.8921 4.2900 5.6400 3.0800 4.5700 1.56%
2015 4.0476 4.0000 5.2500 3.0000 4.5000 15.38%
2014 2.6708 2.5000 5.0000 1.3000 3.9000 57.26%
2013 2.2366 2.7600 2.9000 1.3000 2.4800 -10.14%
2012 3.6102 3.0000 4.3100 2.7500 2.7600 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.170B $0.000B
Volition RX Ltd is a life sciences company engaged in developing a range of blood-based epigenetic cancer diagnostic tests. Its tests are designed to detect the nucleosome patterns that are specific to cancer in the blood, and identify some of the major nucleosome varieties that differ between cancer types. The Company's development activities are primarily centered in Belgium. Volition RX Ltd is based in Singapore.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $134.727B 8.97
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.500B 21.17
Biohaven Pharmaceutical Holding (BHVN) United States $8.865B 0.00
Emergent Biosolutions (EBS) United States $2.891B 6.97
Arcus Biosciences (RCUS) United States $2.641B 0.00
Myovant Sciences (MYOV) United Kingdom $2.145B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.998B 0.00
Zymeworks (ZYME) Canada $1.380B 0.00
Ambrx Biopharma (AMAM) United States $0.521B 0.00
SQZ Biotechnologies (SQZ) United States $0.427B 0.00
Enzo Biochem (ENZ) United States $0.175B 51.71